BIO-key International (NASDAQ:BKYI) Issues Q4 2023 Earnings Guidance

BIO-key International (NASDAQ:BKYI) issued an update on its fourth quarter 2023 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of -5.540–5.540 for the period. The company issued revenue guidance of -. BIO-key International also updated its FY 2023 guidance to -11.450–11.450 EPS.

BIO-key International Stock Performance

Shares of BIO-key International stock traded up $0.06 on Monday, reaching $2.16. 45,206 shares of the company were exchanged, compared to its average volume of 157,179. BIO-key International has a 1-year low of $1.74 and a 1-year high of $15.30. The firm has a market cap of $1.64 million, a price-to-earnings ratio of -0.13 and a beta of 0.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.59 and a current ratio of 1.30. The company’s 50-day moving average is $1.97 and its two-hundred day moving average is $3.73.

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.